Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: An industrially feasible approach

References

• Jain A, Gupta Y, Jain SK. (2007). Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J Pharm Pharm Sci, 10:86–128.
   PubMed Web of Science ®Google Scholar
• http://globocan.iarc.fr/factsheets/cancers/colorectal.asp (Accessed on 19 Jan. 2012).
   Google Scholar
• Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH. (1982). In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res, 42:450–456.
   PubMed Web of Science ®Google Scholar
• Wei H, Qing D, De-Ying C, Bai X, Li-Fang F. (2008). Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm, 348:35–45.
   PubMed Web of Science ®Google Scholar
• Shishu Gupta, N, Aggarwal N. (2007). Stomach-specific drug delivery of 5-Fluorouracil using floating alginate beads. AAPS Pharm Sci Tech, 8: E143–E149.
   PubMed Web of Science ®Google Scholar
• Goto T, Tomizawa N, Kobayashi E, Fujimura A. (2004). A comparative pharmacology study between the intracolonic and oral routes of 5-FU administration in a colon cancer-bearing Yoshida sarcoma rat model. J Pharmacol Sci, 95:163–173.
   PubMed Web of Science ®Google Scholar
• Chirstophidis N, Vajda FJ, Lucas I, Drummer O, Moon WJ, Louis WJ. (1978). Fluorouracil therapy in patients with carcinoma of the large bowel: A pharmacokinetic comparison of various rates and routes of administration. Clin Pharmacokinet, 3:330–336.
   PubMed Web of Science ®Google Scholar
• Basit AW. (2005). Advances in colonic drug delivery. Drugs, 65:1991–2007.
   PubMed Web of Science ®Google Scholar
• Asghar LF, Chandran S. (2006). Multiparticulate formulation approach to colon specific drug delivery: Current perspectives. J Pharm Pharm Sci, 9:327–338.
   PubMed Web of Science ®Google Scholar
• Lai H, Zhu F, Yuan W, He N, Zhang Z, Zhang X et al. (2011). Development of multiple-unit colon-targeted drug delivery system by using alginate: In vitro and in vivo evaluation. Drug Dev Ind Pharm, 37:1347–1356.
   PubMed Web of Science ®Google Scholar
• Watts PJ, Lllum L. (1997). Colonic drug delivery. Drug Dev Ind Pharm, 23:893–913.
   Web of Science ®Google Scholar
• Sinha VR, Kumria R. (2004). Polysaccharide matrices for microbially triggered drug delivery to the colon. Drug Dev Ind Pharm, 30:143–150.
   PubMed Web of Science ®Google Scholar
• Gazzaniga A, Iamartino P, Maffione G, Sangalli ME. (1994). Oral delayed-release system for colonic specific delivery. Int J Pharm, 108:77–83.
   Web of Science ®Google Scholar
• Zhang L, Chen DW, Gao ZB. (2006). [Drug release mechanism of famotidine time-controlled release pellets]. Yao Xue Xue Bao, 41:873–877.
   Google Scholar
• Davis SS, Hardy JG, Taylor MJ, Stockwell A, Whalley DR, Wilson CG. (1984). The in-vivo evaluation of an osmotic device (Osmet) using gamma scintigraphy. J Pharm Pharmacol, 36:740–742.
   PubMed Web of Science ®Google Scholar
• Dvorácková K, Rabišková M, Muselík J, Gajdziok J, Bajerová M. (2011). Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment. Drug Dev Ind Pharm, 37:1131–1140.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Hada R, Nakajima H, Fukuda S, Munakata A. (1997). Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: Colonic luminal pH in normal subjects and patients with Crohn’s disease. Am J Gastroenterol, 92:114–118.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Kawashima Y. (2006). pH-sensitive microparticles for oral drug delivery. J Drug Del Sci Tech, 16:26–34.
   Google Scholar
• Rhodes CT, Porter SC. (1998). Coatings for controlled-release drug delivery systems. Drug Dev Ind Pharm, 24:1139–1154.
   PubMed Web of Science ®Google Scholar
• Akhgari A, Afrasiabi Garekani H, Sadeghi F, Azimaie M. (2005). Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm, 305:22–30.
   PubMed Web of Science ®Google Scholar
• Rubinstein A. (1990). Microbially controlled drug delivery to the colon. Biopharm Drug Dispos, 11:465–475.
   PubMed Web of Science ®Google Scholar
• Kadam VD, Gattani SG. (2010). Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma. Drug Deliv, 17:343–351.
   PubMed Web of Science ®Google Scholar
• Gao C, Huang J, Jiao Y, Shan L, Liu Y, Li Y et al. (2006). In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets. Int J Pharm, 322:104–112.
   PubMed Web of Science ®Google Scholar
• Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol, 27:48–49.
   PubMed Web of Science ®Google Scholar
• Philip AK, Pathak K. (2006). Osmotic flow through asymmetric membrane: A means for controlled delivery of drugs with varying solubility. AAPS Pharm Sci Tech, 7:56.
   PubMedGoogle Scholar
• Blanco MD, Guerrero S, Benito M, Fernández A, Teijón C, Olmo R, Katime I, Teijón JM. (2011). In vitro and in vivo evaluation of a folate-targeted copolymeric submicrohydrogel based on n-isopropylacrylamide as 5-Fluorouracil delivery system. Polymers, 3:1107–1125.
   Web of Science ®Google Scholar
• Erkoboni DF. (2003). Extrusion/Spheronization. In: Ghebre-Sellassie I, Martin C, (ed.) Pharmaceutical Extrusion Technology. New York: Marcel Dekker Inc, pp. 249–280.
   Google Scholar
• Mezreb N, Charrueau C, Boy P, Allain P, Chaumeil JC. (2004). Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: Optimization of the processing parameters and water content. Drug Dev Ind Pharm, 30:481–490.
   PubMed Web of Science ®Google Scholar
• Vervaet C, Baert L, Remon JP. (1995). Extrusion-spheronisation A literature review. Int J Pharm, 116:131–146.
   Web of Science ®Google Scholar
• Häring A, Vetchý D, Janovská L, Krejcová K, Rabisková M. (2008). Differences in characteristics of pellets prepared by different pelletization methods. Drug Dev Ind Pharm, 34:289–296.
   PubMed Web of Science ®Google Scholar
• Hileman GA, Goskonda SR, Spalitto AJ, Upadrashta SM. (1993). Response surface optimization of high dose pellets by extrusion and spheronization. Int J Pharm, 100:71–79.
   Web of Science ®Google Scholar
• Knop K. (1996). Influence of buffer solution composition on drug release from pellets coated with neutral and quaternary acrylic polymers and on swelling of free polymer films. Eur J Pharm Sci, 4:293–300.
   Web of Science ®Google Scholar
• Zhao X, Li G, Zhang L, Tao X, Guan T, Hong M et al. (2010). Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin. Int J Pharm, 400:42–48.
   PubMed Web of Science ®Google Scholar
• Amighi K, Moes AJ. (1997). Influence of curing conditions on the drug release rate from Eudragit® NE30D film coated sustained-release theophylline pellets. STP Pharma Sci, 7:141–147.
   Google Scholar
• Sriamornsak P, Nunthanid J, Luangtana-anan M, Puttipipatkhachorn S. (2007). Alginate-based pellets prepared by extrusion/spheronization: A preliminary study on the effect of additive in granulating liquid. Eur J Pharm Biopharm, 67:227–235.
   PubMed Web of Science ®Google Scholar